Navigation Links
Study identifies a simple way to reduce healthcare costs
Date:7/18/2013

MAYWOOD, Il. - A study led by a Loyola University Medical Center ENT physician provides a case study of a simple action that can reduce healthcare costs without compromising care.

Matthew Kircher, MD, and colleagues examined one of the costs associated with surgery to remove a type of cyst, called a cholesteatoma, from the middle ear. Otologists routinely send specimens to the pathology lab, but the study found this doesn't appear to be necessary.

The study found that in 178 cases involving seven otologists, there was virtually perfect agreement between the otologists' findings and the official diagnoses from the pathology reports. Since the otologists were always right, there appeared to be no need to go through the expense of confirming their findings.

Results are published online ahead of print in the Laryngoscope journal.

The results are similar to other studies that have concluded it's not always necessary to send tonsillectomy specimens to the pathology lab.

The increased cost of routine cholesteatoma pathologic evaluation should be considered among future healthcare cost-containing measures, because the clinical utility appears to be low, Kircher and colleagues wrote.

About 18,000 cases of cholesteatoma are treated each year in the United States. Medicare pays $62 for a microscopic evaluation of a specimen, while private insurers can pay much more. Researchers conservatively estimated that not doing these evaluations could save more than $1 million per year.

"Although this number is small when considering the larger context of health care spending, we believe that this cost analysis represents a simple healthcare cost-containment opportunity," Kircher and colleagues wrote.

A cholesteatoma is a collection of trapped cells and other waste material that slough off into a pocket in the middle ear. As the cyst grows, it can break down middle ear bones and other nearby structures, causing hearing loss, dizziness, tinnitus and facial paralysis.

The study was conducted at the Michigan Ear Institute, where Kircher (first author) completed a neurotology fellowship before recently joining Loyola.

Kircher and colleagues reviewed 178 cases and found the "Cohen's kappa value" between otologists and pathologists was 0.93. A Cohen kappa value measures the agreement between two raters. Statistically, any rating higher than 0.81 is considered a perfect agreement. Researchers said larger studies might help to confirm their findings.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: